Charles Hannum
Jewish Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles Hannum.
Cell | 1983
John W. Kappler; Ralph T. Kubo; Kathryn Haskins; Charles Hannum; Philippa Marrack; Michele Pigeon; Bradley W. McIntyre; James P. Allison; Ian S. Trowbridge
The variability of the MHC restricted receptor on murine T cells was examined by comparing tryptic peptide fingerprints of the receptor isolated fom three T cell hybridomas and a T cell tumor. Both variable and constant peptides were seen. Constant peptides were most apparent when comparing receptors from the same mouse strain. Peptide fingerprints of receptors from two independent T cell hybridomas with the same idiotype and specificity were identical. We also describe a molecule detected on the surface of a human T cell leukemia whose properties were identical to those reported for the MHC receptor on normal human T cells. The molecule was a dimer of 85,000-90,000 MW containing a 46,000 MW acidic alpha-chain and an unrelated 40,000 MW neutral beta-chain.
Archive | 1985
Kathryn Haskins; Neal Roehm; Charles Hannum; Janice White; Ralph T. Kubo; Philippa Marrack; John Kappler
In the past two years, the major histocompatibility complex (MHC)-restricted receptor for antigen on T cells has been identified by several laboratories through the use of clone-specific antibodies which recognize idiotypic determinants on T cell antigen receptors. Studies with these antibodies, summarized in a recent review (1) have established that the antigen/MHC recognition structures on T cells (a) are idiotypic molecules as indicated by the highly specific nature of their binding to the anti-receptor antibodies; (b) can be functionally inhibited or stimulated through interaction with clone-specific antibodies, suggesting that the specific recognition of antigen and MHC involves a single binding site; (c) are 85–90,000 dalton glycoproteins consisting of two heterodimeric disulfide-linked subunits; and (d) contain variable and constant peptide regions in both the alpha and the beta chains. The biochemical characterization of the receptor with the clone-specific antibodies has since been confirmed and extended by recent reports on the genomic organization of the receptor β chain (2–6).
Nature | 1990
Stephen P. Eisenberg; Ronald Evans; William P. Arend; Evie Verderber; Michael T Brewer; Charles Hannum; Robert C. Thompson
Nature | 1990
Charles Hannum; Carol J. Wilcox; William P. Arend; Fenneke G. Joslin; David Dripps; Patricia L. Heimdal; Lyman G. Armes; Andreas Sommer; Stephen P. Eisenberg; Robert C. Thompson
Journal of Immunology | 1989
William P. Arend; Fenneke G. Joslin; R C Thompson; Charles Hannum
Journal of Experimental Medicine | 1983
Philippa Marrack; Richard Shimonkevitz; Charles Hannum; Kathryn Haskins; John W. Kappler
Nature | 1984
Charles Hannum; John W. Kappler; Ian S. Trowbridge; Philippa Marrack; John H. Freed
Journal of Experimental Medicine | 1987
Charles Hannum; Philippa Marrack; Ralph T. Kubo; John W. Kappler
Journal of Immunology | 2006
John W. Kappler; Ralph T. Kubo; Kathryn Haskins; Charles Hannum; Philippa Marrack; Michele Pigeon; Bradley W. McIntyre; James P. Allison; Ian S. Trowbridge
Archive | 2000
William P. Arend; Stephen P. Eisenburg; Charles Hannum; Fenneke G. Joslin; Andreas Sommer; Robert C. Thompson; アレンド,ウィリアム,ピー.; エイゼンバーグ,ステファン,ピー.; ジョスリン,フェネック,ジー.; ソマー,アンドリアス; トムプソン,ロバート,シー.; ハノン,チャールズ,エッチ.